Mounjaro maker slams ‘knock-off’ GLP-1s over ‘safety risks’

Lilly said it discovered an impurity during testing of tirzepatide compounded with B12 (Shutterstock)
Darcy Jimenez

Read more by Darcy Jimenez

Darcy joined C+D as a senior reporter in August 2025. She has been a journalist for several years, writing news and features across a range of areas, including healthcare and the pharmaceutical industry.

Latest from Regulation

More from News